METRONIDAZOLE TABLE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F0441 to DMS Pharmaceutical Group Inc on August 19, 2026, for the procurement of Metronidazole tablets under National Stock Number 6505008901840. This award was issued as a delivery order under the broader base administrative contract SPE2DX25D9900, which was originally established by DLA Troop Support Medical Supply Chain FSB on April 2, 2025, to replace a previous agreement. Shortly after the award date, modification P00001 was issued by DLA Troop Support to terminate the contract for the government's convenience. This action cancelled line item 0001 at no cost to the government, resulting in a total contract value decrease of 55.90 dollars, bringing the final contract price to 0.00 dollars.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
